| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: MEMY |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Investment Bank |
| Days In Registration |
104 |
| Date Filed |
23-Dec-2003 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Memory Pharmaceuticals Corp is a biopharmaceutical company, headquartered in Montvale, New Jersey. The company is focused on developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders. The company was founded in 1998. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
20.19M |
| Contact |
- |
| Number of Employees |
55 |
|
| Original Filing Information |
| US |
| Shares Filed |
5.0M |
| Secondary Shares Filed | 5.0M |
| · As a Percent |
100.0 |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
750.0K |
| File Amount |
$70.0M |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
Current Filing Information
(Amended 17-Mar-2004) |
|
US |
|
Shares Filed |
5.0M |
| Secondary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
$70.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
|
